Cardiovascular diseases, especially myocardial ischemia, have been a leading cause of death worldwide for several decades. Despite major advances in the diagnostic and therapeutic modalities available for the clinical management of patients with cardiovascular disease, significant limitations remain. The use of very small molecular particles has recently emerged as a novel technique for diagnostic imaging and treatment of a variety of disease processes and can be broadly classified under the category Nanomedicine. Many diagnostic and therapeutic modalities based on these small molecular particles have become part of routine clinical practice, such as liposomal amphotericin B for the treatment of fungal infections and iron nanoparticles for imaging liver tumors. In this review, we discuss the potential applications of nanomedicine in the management of cardiovascular diseases.
Issue Section:
Research Papers
References
1.
Wagner
, V.
, Dullaart
, A.
, Bock
, A. K.
, and Zweck
, A.
, 2006, “The Emerging Nanomedicine Landscape
,” Nat. Biotechnol.
, 24
, pp. 1211
–1217
.2.
Mulder
, W. J.
, Cormode
, D. P.
, Hak
, S.
, Lobatto
, M. E.
, Silvera
, S.
, and Fayad
, Z. A.
, 2008, “Multimodality Nanotracers for Cardiovascular Applications
,” Nat. Clin. Pract. Cardiovasc. Med.
, 5
(Suppl 2
), pp. S103
–S111
.3.
Koo
, O. M.
, Rubinstein
, I.
, and Onyuksel
, H.
, 2005, “Role of Nanotechnology in Targeted Drug Delivery and Imaging: A Concise Review
,” Nanomedicine
, 1
(3
), pp. 193
–212
.4.
Winter
, P. M.
, Neubauer
, A. M.
, Caruthers
, S. D.
, Harris, T. D., Robertson, J. D., Williams, T. A., Schmieder, A. H., Hu, G., Allen, J. S., Lacy, E. K., Zhang, H., Wickline, S. A., and Lanza, G. M., 2006, “Endothelial Alpha(v)beta3 Integrin-Targeted Fumagillin Nanoparticles Inhibit Angiogenesis in Atherosclerosis
,” Arterioscler. Thromb., Vasc. Biol.
, 26
, pp. 2103
–2109
.5.
Zimmermann
, T. S.
, Lee
, A. C.
, Akinc
, A.
, Bramlage, B., Bumcrot, D., Fedoruk, M. N., Harborth, J., Heyes, J. A., Jeffs, L. B., John, M., Judge, A. D., Lam, K., McClintock, K., Nechev, L. V., Palmer, L. R., Racie, T., Röhl I., Seiffert, S., Shanmugam, S., Sood, V., Soutschek, J., Toudjarska, I., Wheat, A. J., Yaworski, E., Zedalis, W., Koteliansky, V., Manoharan, M., Vornlocher, H. P., and MacLachlan, I., 2006, “RNAi-Mediated Gene Silencing in Non-Human Primates
,” Nature (London)
, 441
(7089
), pp. 111
–114
.6.
Asmatulu
, R.
, Zalich
, M. A.
, Claus
, R. O.
, and Riffle, J. S., 2005, “Synthesis, Characterization and Targeting of Biodegradable Magnetic Nanocomposite Particles by External Magnetic Fields
,” J. Magn. Magn. Mater.
, 292
, pp. 108
–109
.7.
Rahimi
, M.
, Kilaru
, S.
, Sleiman
, G. E.
, Saleh, A., Rudkevich, D., and Nguyen, K., 2008, “Synthesis and Characterization of Thermo-Sensitive Nanoparticles for Drug Delivery Applications
,” J. Biomed. Nanotechnol.
, 4
, pp. 482
–490
.8.
Salehi
, R.
, Arsalani
, N.
, Davaran
, S.
, and Entezami, A. A., 2009, “Synthesis and Characterization of Thermosensitive and pH-sensitive poly (N-isopropylacrylamide-acrylamide-vinylpyrrolidone) for use in Controlled Release of Naltrexone
,” J. Biomed. Mater. Res. Part A
, 89
, pp. 919
–928
.9.
Iyer
, A. K.
, Khaled
, G.
, Fang
, J.
, and Maeda, H., 2006, “Exploiting the Enhanced Permeability and Retention Effect for Tumor Targeting
,” Drug Discovery Today
, 11
(17–18
), pp. 812
–818
.10.
de Lussanet
, Q. G.
, Backes
, W. H.
, Griffioen
, A. W.
, van Engelshoven, J. M., and Beets-Tan, R. G., 2003, “Gadopentetate Dimeglumine Versus Ultrasmall Superparamagnetic Iron Oxide for Dynamic Contrast-Enhanced MR Imaging of Tumor Angiogenesis in Human Colon Carcinoma in Mice
,” Radiology
, 229
(2
), pp. 429
–438
.11.
Gao
, X.
, Cui
, Y.
, Levenson
, R. M.
, Chung
, L. W.
, and Nie, S., 2004, “In Vivo Cancer Targeting and Imaging With Semiconductor Quantum Dots
,” Nat. Biotechnol.
, 22
(8
), pp. 969
–976
.12.
Tian
, B.
, Cohen-Karni
, T.
, Qing
, Q.
, Duan, X., Xie, P., and Lieber, C. M., 2010, “Three-Dimensional, Flexible Nanoscale Field-Effect Transistors as Localized Bioprobes
,” Science
, 329
, pp. 830
–834
.13.
Goldberg
, M.
, Langer
, R.
, and Jia
, X.
, 2007, “Nanostructured Materials for Applications in Drug Delivery and Tissue Engineering
,” J. Biomater. Sci., Polym. Ed.
, 18
(3
), pp. 241
–268
.14.
Beutner
, R.
, Michael
, J.
, Schwenzer
, B.
, and Scharnweber, D., 2010, “Biological Nano-Functionalization of Titanium-Based Biomaterial Surfaces: A Flexible Toolbox
,” J. R. Soc., Interface
, 7
(Suppl 1
), pp. S93
–S105
.15.
Taylor
, E.
and Webster
, T. J.
, 2011, “Reducing Infections Through Nanotechnology and Nanoparticles
,” Int. J. Nanomed.
, 6
, pp. 1463
–1473
.16.
Ajeesh
, M.
, Francis
, B. F.
, Annie
, J.
, and Harikrishna Varma, P. R., 2010, “Nano Iron Oxide-Hydroxyapatite Composite Ceramics With Enhanced Radiopacity
,” J. Mater. Sci. Mater. Med.
, 21
(5
), pp. 1427
–1434
.17.
Viles-Gonzalez
, J. F.
, Fuster
, V.
, and Badimon
, J. J.
, 2004, “Atherothrombosis: A Widespread Disease With Unpredictable and Life-Threatening Consequences
,” Eur. Heart J.
, 25
(14
), pp. 1197
–1207
.18.
Felker
, G. M.
, Thompson
, R. E.
, Hare
, J. M.
, Hruban, R. H., Clemetson, D. E., Howard, D. L., Baughman, K. L., and Kasper, E. K., 2000, “Underlying Causes and Long-Term Survival in Patients With Initially Unexplained Cardiomyopathy
,” N. Engl. J. Med.
, 342
, pp. 1077
–1084
.19.
Cohn
, J. N.
, Ferrari
, R.
, and Sharpe
, N.
, 2000, Cardiac Remodeling—Concepts and Clinical Implications: A Consensus Paper From an International Forum on Cardiac Remodeling. Behalf of an International Forum on Cardiac Remodeling
,” J. Am. Coll. Cardiol.
, 1, 35
(3
), pp. 569
–582
.20.
Aleong
, R. G.
, Milan
, D. J.
, and Ellinor
, P. T.
, 2007, “The Diagnosis and Treatment of Cardiac Ion Channelopathies: Congenital Long QT Syndrome and Brugada Ssyndrome
,” Curr. Treat. Options Cardiovasc. Med.
, 9
(5
), pp. 364
–371
.21.
Corrado
, D.
, Basso
, C.
, Thiene
, G.
, McKenna, W. J., Davies, M. J., Fontaliran, F., Nava, A., Silvestri, F., Blomstrom-Lundqvist, C., Wlodarska, E. K., Fontaine, G., and Camerini, F., 1997, “Spectrum of Clinicopathologic Manifestations of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: A Multicenter Study
,” J. Am. Coll. Cardiol.
, 30
, pp. 1512
–1520
.22.
Pyeritz
, R. E.
, “Inherited Diseases of Connective Tissue
,” Cecil Medicine
, 23rd ed., L.
Goldman
and D.
Ausiello
, eds., Saunders Elsevier
, Philadelphia
, 2007, Chap. 281.23.
Mulvagh
, S. L.
, Rakowski
, H.
, Vannan
, M. A.
, Abdelmoneim, S. S., Becher, H., Bierig, S. M., Burns, P. N., Castello, R., Coon, P. D., Hagen, M. E., Jollis, J. G., Kimball, T. R., Kitzman, D. W., Kronzon, I., Labovitz, A. J., Lang, R. M., Mathew, J., Moir, W. S., Nagueh, S. F., Pearlman, A. S., Perez, J. E., Porter, T. R., Rosenbloom, J., Strachan, G. M., Thanigaraj, S., Wei, K., Woo, A., Yu, E. H., and Zoghbi, W. A., 2008, “American Society of Echocardiography Consensus Statement on the Clinical Applications of Ultrasonic Contrast Agents in Echocardiography
,” J. Am. Soc. Echocardiogr.
, 21
, pp. 1179
–1201
.24.
Kaufmann
, B. A.
, Sanders
, J. M.
, Davis
, C.
, and Xie, A., 2007, “Molecular Imaging of Inflammation in Atherosclerosis With Targeted Ultrasound Detection of Vascular Cell Adhesion Molecule-1
,” Circulation
, 116
, pp. 276
–284
.25.
Hamilton
, A.
, Huang
, S. L.
, Warnick
, D.
, Stein, A., Rabbat, M., Madhav, T., Kane, B., Nagaraj, A., Klegerman, M., MacDonald, R., and McPherson, D., 2002, “Left Ventricular Thrombus Enhancement After Intravenous Injection of Echogenic Immunoliposomes
,” Circulation
, 105
, pp. 2772
–2778
.26.
Hyafil
, F.
, Cornily
, J. C.
, Feig
, J. E.
, Gordon, R., Vucic, E., Amirbekian, V., Fisher, E. A., Fuster, V., Feldman, L. J., and Fayad, Z. A., 2007, “Noninvasive Detection of Macrophages Using a Nanoparticulate Contrast Agent for Computed Tomography
,” Nat. Med.
, 13
, pp. 636
–641
.27.
Weisbord
, S. D.
, Mor
, M. K.
, Resnick
, A. L.
, Unruh, M. L., Palevsky, P. M., Levenson, D. J., Cooksey, S. H., Fine, M. J., Kimmel, P. L., and Arnold, R. M., 2008, “Incidence and Outcomes of Contrast-Induced AKI Following Computed Ttomography
,” Clin. J. Am. Soc. Nephrol.
, 3
(5
), pp. 1274
–1281
.28.
Cormode
, D. P.
, Roessl
, E.
, Thran
, A.
, Skajaa, T., Gordon, R. E., Schlomka, J. P., Fuster, V., Fisher, E. A., Mulder, W. J., Proksa, R., and Fayad, Z. A., 2010, “Atherosclerotic Plaque Composition: Analysis With Multicolor CT and Targeted Gold Nanoparticles
,” Radiology
, 256
(3
), pp. 774
–782
.29.
Pan
, D.
, Roessl
, E.
, Schlomka
, J. P.
, Caruthers, S. D., Senpan, A., Scott, M. J., Allen, J. S., Zhang, H., Hu, G., Gaffney, P. J., Choi, E. T., Rasche, V., Wickline, S. A., Proksa, R., and Lanza, G. M., 2010, “Computed Tomography in Color: NanoK-Enhanced Spectral CT Molecular Imaging
,” Angew. Chem., Int. Ed. Engl.
, 10, 49
(50
), pp. 9635
–9639
.30.
Kooi
, M. E.
, Cappendijk
, V. C.
, Cleutjens
, K. B.
, Kessels, A. G., Kitslaar, P. J., Borgers, M., Frederik, P. M., Daemen, M. J., and van Engelshoven, J. M., 2003, “Accumulation of Ultrasmall Superparamagnetic Particles of Iron Oxide in Human Atherosclerotic Plaques Can Be Detected by In Vivo Magnetic Resonance Imaging
." Circulation
, 107
, pp. 2453
–2458
.31.
Briley-Saebo
, K. C.
, Shaw
, P. X.
, Mulder
, W. J.
, Choi, S. H., Vucic, E., Aguinaldo, J. G., Witztum, J. L., Fuster, V., Tsimikas, S., and Fayad, Z. A., “Targeted Molecular Probes for Imaging Atherosclerotic Lesions With Magnetic Resonance Using Antibodies That Recognize Oxidation-Specific Epitopes
,” Circulation
, 117
, pp. 3206
–3215
.32.
Jaffer
, F. A.
, Nahrendorf
, M.
, Sosnovik
, D.
, Kelly, K. A., Aikawa, E., and Weissleder, R., 2006, “Cellular Imaging of Inflammation in Atherosclerosis Using Magnetofluorescent Nanomaterials
,” Mol. Imaging
, 5
, pp. 85
–92
.33.
Amirbekian
, V.
, Lipinski
, M. J.
, Briley-Saebo
, K. C.
, Amirbekian, S., Aguinaldo, J. G., Weinreb, D. B., Vucic, E., Frias, J. C., Hyafil, F., Mani, V., Fisher, E. A., and Fayad, Z. A., 2007, “Detecting and Assessing Macrophages In Vivo to Evaluate Atherosclerosis Noninvasively Using Molecular MRI
,” Proc. Natl. Acad. Sci. U.S.A.
, 104
, pp. 961
–966
.34.
Oostendorp
, M.
, Douma
, K.
, Wagenaar
, A.
, Slenter, J. M., Hackeng, T. M., van Zandvoort, M. A., Post, M. J., and Backes, W. H., 2010, “Molecular Magnetic Resonance Imaging of Myocardial Angiogenesis After Acute Myocardial Infarction
,” Circulation
, 121
, pp. 775
–783
.35.
Flogel
, U.
, Ding
, Z.
, Hardung
, H.
, Jander, S., Reichmann, G., Jacoby, C., Schubert, R., and Schrader, J., 2008, “In Vivo Monitoring of Inflammation After Cardiac and Cerebral Ischemia by Fluorine Magnetic Resonance Imaging
,” Circulation
, 118
, pp. 140
–148
.36.
Sanders
, H. M.
, Strijkers
, G. J.
, Mulder
, W. J.
, Huinink, H. P., Erich, S. J., Adan, O. C., Sommerdijk, N. A., Merkx, M., and Nicolay, K., 2009, “Morphology, Binding Behavior and MR-Properties of Paramagnetic Collagen-Binding Liposomes
,” Contrast Media Mol Imaging
, 4
(2
), pp. 81
–88
.37.
Sosnovik
, D. E.
, Garanger
, E.
, Aikawa
, E.
, Nahrendorf, M., Figuiredo, J. L., Dai, G., Reynolds, F., Rosenzweig, A., Weissleder, R., and Josephson, L., 2009, “Molecular MRI of Cardiomyocyte Apoptosis With Simultaneous Delayed-Enhancement MRI Distinguishes Apoptotic and Necrotic Myocytes In Vivo: Potential for Mid-Myocardial Salvage in Acute Ischemia
,” Circ Cardiovasc Imaging
2
, 460
–467
.38.
Nahrendorf
, M.
, Jaffer
, F. A.
, Kelly
, K. A.
, Sosnovik, D. E., Aikawa, E., Libby, P., and Weissleder, R., 2006, “Noninvasive Vascular Cell Adhesion Molecule-1 Imaging Identifies Inflammatory Activation of Cells in Atherosclerosis
,” Circulation
, 114
, pp. 1504
–1511
.39.
Li, D., Patel, A. R., Klibanov, A. L., Kramer, C. M., Ruiz, M., Kang, B. Y., Mehta, J. L., Beller, G. A., Glover, D. K., and Meyer, C. H., 2010, “
Molecular Imaging of Atherosclerotic Plaques Targeted to Oxidized LDL Receptor LOX-1 by SPECT/CT and Magnetic Resonance
,” Circ Cardiovasc Imaging
, 3
, pp. 464–472.40.
Lees
, A. M.
, Lees
, R. S.
, Schoen
, F. J.
, Isaacsohn, J. L., Fischman, A. J., McKusick, K. A., and Strauss, H. W., 1988, “Imaging Human Atherosclerosis With 99mTc-Labeled Low Density Lipoproteins
,” Arteriosclerosis
, 8
(5
), pp. 461
–470
.41.
Nahrendorf
, M.
, Zhang
, H.
, Hembrador
, S.
, Panizzi, P., Sosnovik, D. E., Aikawa, E., Libby, P., Swirski, F. K., and Weissleder, R., 2008, “Nanoparticle PET-CT Imaging of Macrophages in Inflammatory Atherosclerosis
,” Circulation
, 117
, PP. 379
–387
.42.
Virmani
, R.
, Burke
, A. P.
, Kolodgie
, F. D.
, and Farb, A., 2002, “Vulnerable Plaque: The Pathology of Unstable Coronary Lesions
,” J. Interv. Cardiol.
, 15
(6
), pp. 439
–446
.43.
Briley-Saebo
, K. C.
, Cho
, Y. S.
, Shaw
, P. X.
, Ryu, S. K., Mani, V., Dickson, S., Izadmehr, E., Green, S., Fayad, Z. A., and Tsimikas, S., 2011, “Targeted Iron Oxide Particles for In Vivo Magnetic Resonance Detection of Atherosclerotic Lesions With Antibodies Directed to Oxidation-Specific Epitopes
,” J. Am. Coll. Cardiol.
, 57
, pp. 337
–347
.44.
Trivedi
, R. A.
, U-King-Im
, J. M.
, Graves
, M. J.
, Cross, J. J., Horsley, J., Goddard, M. J., Skepper, J. N., Quartey, G., Warburton, E., Joubert, I., Wang, L., Kirkpatrick, P. J., Brown, J., and Gillard, J. H., 2004, “In Vivo Detection of Macrophages in Human Carotid Atheroma: Temporal Dependence of Ultra-Small Superparamagnetic Particles of Iron Oxide-Enhanced MRI
,” Stroke
, 35
, pp. 1631
–1635
.45.
Tang
, T. Y.
, Howarth
, S. P.
, Miller
, S. R.
, Graves, M. J., Patterson, A. J., U-King-Im, J. M., Li, Z. Y., Walsh, S. R., Brown, A. P., Kirkpatrick, P. J., Warburton, E. A., Hayes, P. D., Varty, K., Boyle, J. R., Gaunt, M. E., Zalewski, A., and Gillard, J. H., 2009, “The ATHEROMA (Atorvastatin Therapy: Effects on Reduction of Macrophages Activity) study. Evaluation Using Ultrasmall Superparamagnetic Iron Oxide-Enhanced Magnetic Resonance Imaging in Carotid Disease
,” J. Am. Coll. Cardiol.
53
, pp. 2039
–2050
.46.
Flacke
, S.
, Fischer
, S.
, Scott
, M.
, Fuhrhop, R. J., Allen, J. S., McLean, M., Winter, P., Sicard, G. A., Gaffney, P. J., Wickline, S. A., and Lanza, G. M., 2001, “A Novel MRI Contrast Agent for Molecular Imaging of Fibrin: Implications for Detecting Vulnerable Plaques
,” Circulation
, 104
, pp. 1280
–1285
.47.
McCarthy
, J. R.
, Korngold
, E.
, Weissleder
, R.
, and Jaffer, F. A., 2010, “A Light-Activated Theranostic Nanoagent for Targeted Macrophage Ablation in Inflammatory Atherosclerosis
,” Small
, 6
(18
), pp. 2041
–2049
.48.
Lobatto
, M. E.
, Fayad
, Z. A.
, Silvera
, S.
, Vucic, E., Calcagno, C., Mani, V., Dickson, S. D., Nicolay, K., Banciu, M., Schiffelers, R. M., Metselaar, J. M., van Bloois, L., Wu, H. S., Fallon, J. T., Rudd, J. H., Fuster, V., Fisher, E. A., Storm, G., and Mulder, W. J., 2010, “Multimodal Clinical Imaging to Longitudinally Assess a Nanomedical Anti-Inflammatory Treatment in Experimental Atherosclerosis
,” Mol. Pharm.
, 7
(6
), pp. 2020
–2029
.49.
Takahama
, H.
, Minamino
, T.
, Asanuma
, H.
, Fujita, M., Asai, T., Wakeno, M., Sasaki, H., Kikuchi, H., Hashimoto, K., Oku, N., Asakura, M., Kim, J., Takashima, S., Komamura, K., Sugimachi, M., Mochizuki, N., andKitakaze, M., 2009, “Prolonged Targeting of Ischemic/Reperfused Myocardium by Liposomal Adenosine Augments Cardioprotection in Rats
,” J. Am. Coll. Cardiol.
, 53
(8
), pp. 709
–717
.50.
Hartner
, W. C.
, Verma
, D. D.
, Levchenko
, T. S.
, Bernstein, E. A., and Torchilin, V. P., 2009, “ATP-Loaded Liposomes for Treatment of Myocardial Ischemia
,” Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol.
, 1
(5
), pp. 530
–539
.51.
Silva
, G. V.
, Litovsky
, S.
, Assad
, J. A.
, Sousa, A. L., Martin, B. J., Vela, D., Coulter , S. C., Lin, J., Ober, J., Vaughn, W. K., Branco, R. V., Oliveira, E. M., He, R., Geng, and Y. J., Willerson, J. T., Perin EC. 2005, “Mesenchymal Stem Cells Differentiate Into an Endothelial Phenotype, Enhance Vascular Density, and Improve Heart Function in a Canine Chronic Ischemia Model
,” Circulation
, 111
, pp. 150
–156
.52.
Oda
, S.
, Nagahama
, R.
, Nakano
, K.
, Matoba, T., Kubo, M., Sunagawa, K., Tominaga, R., and Egashira, K., 2010, “Nanoparticle-Mediated Endothelial Cell-Selective Delivery of Pitavastatin Induces Functional Collateral Arteries (Therapeutic Arteriogenesis) in a Rabbit Model of Chronic Hind Limb Ischemia
,” J. Vasc. Surg.
, 52
, pp. 412
–420
.53.
Kubo
, M.
, Egashira
, K.
, Inoue
, T.
, Koga, J., Oda, S., Chen, L., Nakano, K., Matoba, T., Kawashima, Y., Hara, K., Tsujimoto, H., Sueishi, K., Tominaga, R., and Sunagawa, K., 2009, “Therapeutic Neovascularization by Nanotechnology-Mediated Cell-Selective Delivery of Pitavastatin Into the Vascular Endothelium
,” Arterioscler. Thromb., Vasc. Biol.
29
, pp. 796
–801
.54.
Kim
, J.
, Cao
, L.
, Shvartsman
, D.
, Silva, E. A., Mooney, D. J., 2011, “Targeted Delivery of Nanoparticles to Ischemic Muscle for Imaging and Therapeutic Angiogenesis
,” Nano Lett.
, 11
, pp. 694
–700
.55.
Kushner
, F. G.
, Hand
, M.
, Smith
, S. C.
, King, S. B.,Anderson, J. L., Antman, E. M., Bailey, S. R., Bates, E. R., Blankenship, J. C., Casey, D. E.,Green, L. A., Hochman, J. S., Jacobs, A. K., Krumholz, H. M., Morrison, D. A., Ornato, J. P., Pearle, D. L., Peterson, E. D., Sloan, M. A., Whitlow, P. L., and Williams, D. O., 2009, “Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction (Updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (Updating the 2005 Guideline and 2007 Focused Update)
,” J. Am. Coll. Cardiol.
, 54
, pp. 2205
–2241
.56.
Lanza
, G. M.
, Yu
, X.
, Winter
, P. M.
, Abendschein, D. R., Karukstis, K. K., Scott, M. J., Chinen, L. K., Fuhrhop, R. W., Scherrer, D. E., and Wickline, S. A., 2002, “Targeted Antiproliferative Drug Delivery to Vascular Smooth Muscle Cells With a Magnetic Resonance Imaging Nanoparticle Contrast Agent: Implications for Rational Therapy of Restenosis,” Circulation
, pp.
106
, pp. 2842
–2847
.57.
Joner
, M.
, Morimoto
, K.
, Kasukawa
, H.
, Abendschein, D. R., Karukstis, K. K., Scott, M. J., Chinen, L. K., Fuhrhop, R. W., Scherrer, D. E., and Wickline,S. A., 2008, “Site-Specific Targeting of Nanoparticle Prednisolone Reduces In-Stent Restenosis in a Rabbit Model of Established Atheroma
,” Arterioscler. Thromb., Vasc. Biol.
, 28
(11
), pp. 1960
–1966
.58.
Helm
, P. A.
, Caravan
, P.
, French
, B. A.
, Jacques, V., Shen, L., Xu, Y., Beyers, R. J., Roy, R. J., Kramer, C. M., andEpstein, F. H., 2008, “Postinfarction Myocardial Scarring in Mice: Molecular MR Imaging With Use of a Collagen-Targeting Contrast Agent
,” Radiology
, 247
, pp. 788
–796
.59.
Lukyanov
, A. N.
, Harder
, W. C.
, and Torchilin
, V. P.
, 2004, “Increased Accumulation of PEG-PE Micelles in the Area of Experimental Myocardial Infarction in Rabbits
,” J. Controlled Release
, 94
, pp. 187
–193
.60.
Yu
, L.
, Scherlag
, B. J.
, Dormer
, K.
, Nguyen, K. T., Pope, C., Fung, K. M., Po,S. S., 2010, “Autonomic Denervation With Magnetic Nanoparticles
,” Circulation
, 122
, pp. 2653
–2659
.61.
Kimura
, S.
, Egashira
, K.
, Chen
, L.
, Nakano, K., Iwata, E., Miyagawa, M., Tsujimoto, H., Hara, K., Morishita, R., Sueishi, K., Tominaga, R., and Sunagawa, K., 2009, “Nanoparticle-Mediated Delivery of Nuclear Factor-κB Decoy Into Lungs Ameliorates Monocrotaline-Induced Pulmonary Arterial Hypertension
,” Hypertension
, 53
, pp. 877
–883
.62.
Chen
, L.
, Nakano
, K.
, Kimura
, S.
, Matoba, T., Iwata, E., Miyagawa, M., Tsujimoto, H., Nagaoka, K., Kishimoto, J., Sunagawa, andK., Egashira, K., 2011, “Nanoparticle-Mediated Delivery of Pitavastatin Into Lungs Ameliorates the Development and Induces Regression of Monocrotaline-Induced Pulmonary Artery Hypertension
,” Hypertension
, 57
, pp. 343
–350
.63.
Aikawa
, E.
, Nahrendorf
, M.
, Sosnovik
, D.
, V. M., Jaffer, F. A., Aikawa, M., and Weissleder R., 2007, “Multimodality Molecular Imaging Identifies Proteolytic and Osteogenic Activities in Early Aortic Valve Disease
,” Circulation
, 115
, pp. 377
–386
.64.
Piper
, C.
, Korfer
, R.
, and Horstkotte
, D.
, 2001, “Prosthetic Valve Endocarditis
,” Heart
, 85
, pp. 590
–593
.Copyright © 2011
by American Society of Mechanical Engineers
You do not currently have access to this content.
